Insys Therapeutics (INSY) Director Buys 10K Shares
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Insys Therapeutics (NASDAQ: INSY) Director, Steven Meyer, bought 10,000 shares on 11/04 at $10.75
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insys Therapeutics Pipeline Shows Long-Term Upside Potential - Oppenheimer
- New York & Co. (NWY) President/COO Buys ~12K Shares
- NRG Energy (NRG) Says It's Aware of 13D Filing, Open to Input from All Shareholders - Bloomberg, Citing Emial
Create E-mail Alert Related CategoriesInsider Trades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!